Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2015-06-01
2018-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Incidence of Acute Kidney Injury and Mortality in Critically Ill Patients: Urinary Chloride as a Prognostic Marker
NCT05542927
Risk Factors and Machine Learning Model for Diuretics Related Acute Kidney Injury
NCT05527054
Serum Ferritin In CKD Patients Serum Ferritin
NCT05947552
Serum Cysteine Rich Protein 61 and Cystatin C for Early Detection of Acute Kidney Injury in Patients With Heart Diseases
NCT05242705
Transition of Acute Kidney Injury to Chronic Kidney Disease
NCT04101110
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Elderly Medical Patients at hospital admission
24 hour urine creatinine excretion
two age corrected calculations of creatinine height index were obtained
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
24 hour urine creatinine excretion
two age corrected calculations of creatinine height index were obtained
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* within 24 hours of hospital admission
Exclusion Criteria
* fever
* malignancy
* liver cirrhosis
* renal impairment
* critically ill patients
* those with any hemodynamic instability were excluded from the study
* patients receiving diuretics
* patients can't stand to obtain their weight and height
* those can't collect 24 hour urine
* the patients refused to participate in the study
60 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Doha Rasheedy
Assistant Professor of Geriatric Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
DOHA RASHEEDY, MD
Role: PRINCIPAL_INVESTIGATOR
Ain Shams University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ain Shams University
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AinShamsGer
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.